Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant

[11] Altuntaş SÇ(2014)Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial Lancet Diabetes Endocrinol. 2 875-84

[12] Evran M(2010)A consensus on criteria for cure of acromegaly J Clin Endocrinol Metab. 95 3141-3148

[13] Sert M(2016)Hyperglycemia in pasireotide-treated patients with acromegaly and its treatment Endocrine. 54 0-1

[14] Tetiker T(2016)Current and emerging aspects of diabetes mellitus in acromegaly Trends Endocrinol Metab. 27 470-83

[15] Mestron A(2010)Biological effects of growth hormone on carbohydrate and lipid metabolism Growth Horm. IGF Res. 20 1-7

[16] Webb SM(1986)Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance Diabetologia. 29 778-83

[17] Astorga R(2007)Growth hormone regulation of p85 expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance Diabetes. 56 1638-46

[18] Benito P(2009)Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects Endocr Rev. 30 152-77

[19] Catala M(1989)Growth hormone is a growth factor for the differentiated pancreatic β-cell Mol Endocrinol. 3 165-73

[20] Gaztambide S(2014)Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients Pituitary. 17 81-89

[11] Altuntaş SÇ(2014)Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial Lancet Diabetes Endocrinol. 2 875-84

[12] Evran M(2010)A consensus on criteria for cure of acromegaly J Clin Endocrinol Metab. 95 3141-3148

[13] Sert M(2016)Hyperglycemia in pasireotide-treated patients with acromegaly and its treatment Endocrine. 54 0-1

[14] Tetiker T(2016)Current and emerging aspects of diabetes mellitus in acromegaly Trends Endocrinol Metab. 27 470-83

[15] Mestron A(2010)Biological effects of growth hormone on carbohydrate and lipid metabolism Growth Horm. IGF Res. 20 1-7

[16] Webb SM(1986)Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance Diabetologia. 29 778-83

[17] Astorga R(2007)Growth hormone regulation of p85 expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance Diabetes. 56 1638-46

[18] Benito P(2009)Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects Endocr Rev. 30 152-77

[19] Catala M(1989)Growth hormone is a growth factor for the differentiated pancreatic β-cell Mol Endocrinol. 3 165-73

[20] Gaztambide S(2014)Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients Pituitary. 17 81-89